Stock, pipeline and biotech catalyst intelligence
Market expectations
Street view at a glance
The average target implies 45.6% downsideTargets are estimates—not guarantees—and can change after company updates.Wall Street consensus
BuyBased on 6 analyst opinionsPrice-target range
$3.52Company profile
Sinovac Biotech is a biotechnology company in the healthcare sector.
Company profile compiled from available company records. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Jul 7, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.